“…There were 1,167 cases with leukopenia and 240 cases with neutropenia. Among these, 14 studies were conducted in IBD (Yang et al, 2014;Asada et al, 2016;Kakuta et al, 2016;Zhu et al, 2016;Chao et al, 2017;Sato et al, 2017;Shah et al, 2017;Kakuta et al, 2018a;Sutiman et al, 2018;Wang et al, 2018;Akiyama et al, 2019;Banerjee et al, 2020;Kang et al, 2020;Xu et al, 2020), nine studies in ALL (Tanaka et al, 2015;Chiengthong et al, 2016;Tanaka et al, 2018;Zhou et al, 2018;Buaboonnam et al, 2019; Choi et al, 2019;Kodidela et al, 2020;Puangpetch et al, 2020;Ramalingam et al, 2021) and seven studies in other autoimmune diseases (autoimmune hepatitis, dermatological diseases and rheumatological diseases) (Kim et al, 2017b;Fei et al, 2018;Yang et al, 2019a;Fan et al, 2019;Huang et al, 2020;Su et al, 2020;Miao et al, 2021). Myelosuppression was categorized based on the onset and characteristics of blood cell type, including of leukopenia and neutropenia.…”